Yamamoto Naoki

Homepage URL (1)： http://kaken.nii.ac.jp/ja/r/70312296

Research field (2)： Pharmacology , Psychiatry

Research keywords (7)： histone , nuclear protein , アメフラシ , RBM10 , 総合失調症 , 大脳皮質 , 抗精神病薬

Research theme for competitive and other funds (14)：

2021 - 2024 細胞核ダイナミクスの分子機能に着目した抗核抗体関連精神疾患の解明
2019 - 2023 Mutations for life lengthening of pancreatic cancer patients: mechanism and proposed theory for practice
2015 - 2019 Unified elucidation of cell pathology of various diseases stemming from alternative splicing regulator RBM10
2014 - 2018 Application of chiral-specificity of amino acids on the novel development of antipsychotic drugs for schizophrenia
2012 - 2016 Investigation of development of new treatment for refractory depression by modification of glutamate neuropterans mission

Show all

MISC (13)：

Nakatani Y, Ishikawa K, Aoki Y, Shimooki T, Yamamoto N, Amano T. Inhibitory effect of atomoxetine on Nav1.2 voltage-gated sodium channel currents. Pharmacol Rep. 2023. in press
Nakatani Y, Yaguchi M, Ogino K, Noguchi R, Yamamoto N, Amano T. Duloxetine ameliorates lipopolysaccharide-induced microglial activation by suppressing iNOS expression in BV-2 microglial cells. Psychopharmacology. 2022. 239. 10. 3133-3143
Uezato A, Jitoku D, Shimazu D, Yamamoto N, Kurumaji A, Iwayama Y, Toyota T, Yoshikawa T, Haroutunian V, Bentea E, et al. Differential genetic associations and expression of PAPST1/SLC35B2 in bipolar disorder and schizophrenia. J Neural Transm. 2022. 129. 7. 913-924
中谷善彦, 山本直樹. 精神疾患. Principal Pharmacotherapy. 改訂3版. 2022. 823-907
小泉友紀暁, 山本直樹, 上里彰仁. フランスにおけるアルコール対策としての法的広告規制. アディクション看護. 2022. 19. 2. 4-9

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page